Avalyn Pharma Inc. Common Stock (AVLN) vs Tandem Diabetes Care, Inc. (TNDM)

A side-by-side comparison of Avalyn Pharma Inc. Common Stock and Tandem Diabetes Care, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Avalyn Pharma Inc. Common Stock logo
AVLN
Avalyn Pharma Inc. Common Stock
$1.13B
$25.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Tandem Diabetes Care, Inc. logo
TNDM
Tandem Diabetes Care, Inc.
$1.11B
$16.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AVLN vs TNDM

growth of $100 · dividends reinvested · last 1y
AVLN -8.3% (-8.3%/yr)TNDM -16.6% (-16.6%/yr)AVLN compounded faster over this window
80100120Start $100$92$83
AVLN TNDM

AVLN vs TNDM: by the numbers

  • •AVLN is the larger company ($1.13B vs $1.11B market cap).
  • •Both run net losses; AVLN's is the smaller (0.00% vs -6.08% net margin).

Metrics side by side

Valuation

MetricAVLNTNDM
P/S ratioN/A1.06
P/B ratio2.838.49

Profitability

MetricAVLNTNDM
Gross margin0.00%56.01%
Operating margin0.00%-4.13%
Net margin0.00%-6.08%
ROEN/A-48.56%
ROIC-67.73%-4.77%

Growth (annualized)

MetricAVLNTNDM
Revenue CAGR (5Y)N/A11.48%
Total return CAGR (5Y)N/A-32.93%

Go deeper

Full AVLN analysisFull TNDM analysisInteractive comparison tool

Dig into the metrics

Avalyn Pharma Inc. Common Stock ROETandem Diabetes Care ROEAvalyn Pharma Inc. Common Stock operating marginTandem Diabetes Care operating marginAvalyn Pharma Inc. Common Stock revenue growthTandem Diabetes Care revenue growthAvalyn Pharma Inc. Common Stock free cash flowTandem Diabetes Care free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.